“All in all, I still believe Chemgenex to be the most undervalued listed life science company on the Australian stock exchange and should currently trading about $5.00”
If Sinatra is right in suggesting the head CXS stock is undervalued, then the CXSOA must be a screaming buy for leverage with a current seller asking only 40c !
CXSOA –
OPTIONS EXPIRING 8 FEB 2012
EXERCISABLE AT $0.68
$0.40 + $0.68 = $1.08 vs Sinatra’s $5
